GEN Exclusives

More »

GEN News Highlights

More »
Mar 13, 2009

Enzo Acquires Assay Designs for $12.2M

  • Enzo Biochem is taking over Assay Designs for $12.2 million in cash. Enzo will thus gain Assay Designs’ drug discovery research product line related to inflammation, immunity, oxidative and cellular stress, steroid and hormone biology, cell signaling, and bioenergetics.

    “Assay Designs has annual revenues exceeding $11 million,” according to Carl Balezentis, president of Enzo Life Sciences. With the transaction, Enzo expects annual revenues to reach $100 million, adds Barry Weiner, president of Enzo Biochem.

    Assay Designs’ kits and reagents for the detection and quantification of small molecules and proteins will complement Enzo Life Sciences’ labeling and detection products for gene sequencing, genetic analysis, and immunological research among others.

    Through the acquisition, Enzo Life Sciences will have operations in New York, Pennsylvania, Michigan, and California as well as facilities in Switzerland, the U.K., and Belgium. The company will have over 50 distributors worldwide.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should “Special K” Get Special Treatment?

In the near term, what is the best way to use ketamine in treating depression?